SMTOY vs TEVA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SMTOY · SUMITOMO ELECTRIC INDUSTRIES UNSPON ADS EACH REP 0.5 ORD SHS$4.43 ▲ 12.72%
TEVA · Teva Pharmaceutical Industries$42.61 ▲ 1.99%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SMTOY -10.1%
- TEVA +75.6%
Head to head
| Metric | SMTOY | TEVA |
|---|---|---|
| Price | $4.43 | $42.61 |
| Change today | ▲ 12.72% | ▲ 1.99% |
| Market cap | $49.73B | $49.72B |
| Return, 3 months | -32.4% | +17.9% |
| Return, year to date | -11.1% | +36.5% |
| Return, 1 year | -7.1% | +77.8% |
| P/E (TTM) | 13.8 | 99.1 |
| P/B | 1.5 | 6.2 |
| P/E percentile vs own 5y | – | 100th |
| Dividend yield | 2.71% | – |
| Revenue growth (YoY, latest qtr) | – | -0.8% |
| Net profit growth (YoY) | – | -303.2% |
| Gross margin | – | 52.5% |
| Operating margin | – | 18.7% |
| Net margin | – | 4.1% |
| Return on equity | – | 9.7% |
| Analyst target vs. price | – | +16.9% |
| Analyst buy share | – | 100% |
| RSI (14) | 30 | 63 |
| 30-day volatility | 91.5% | 26.7% |
| Max drawdown, 1 year | -64.7% | -21.8% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SMTOY is the largest of the group by market value.
- TEVA has returned the most over the past year.
- SMTOY carries the lowest trailing P/E.
- TEVA has been the calmest stock over the last 30 days.